Should I Buy NTNX? NTNX 2026 Analysis

Should You Buy Nutanix Inc (NTNX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

39.460

1 Day change

-5.55%

52 Week Range

83.360

Analysis Updated At

2026/01/26

Nutanix Inc (NTNX) is not a strong buy at this time for a beginner investor with a long-term strategy. The stock is facing multiple challenges, including bearish technical indicators, insider selling, negative news sentiment due to investigations, and a lack of strong proprietary trading signals. While the company has shown solid financial growth in its latest quarter, the ongoing legal scrutiny and reduced revenue guidance create uncertainty. Holding off on investing until these issues are resolved or the stock shows clearer positive momentum is recommended.

Technical Analysis

The technical indicators for NTNX are bearish. The MACD histogram is negative and contracting, RSI is neutral at 21.692, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its key support level of 42.789, with resistance levels at 47.686 and 52.584. Overall, the technical outlook suggests weakness in the stock.

Options Data

Bullish

Open Interest Put-Call Ratio

Bearish

Option Volume Put-Call Ratio

The high put-call volume ratio (1.12) indicates bearish sentiment in the options market, while the open interest put-call ratio (0.38) suggests more interest in calls than puts. Implied volatility is high at 50.76%, with an IV percentile of 82, indicating elevated uncertainty.

Technical Summary

Sell

Buy

Positive Catalysts

Financial performance in Q1 FY2026 showed strong YoY growth: Revenue increased by 13.47%, Net Income by 107.50%, and EPS by 110.00%.
Gross margin improved slightly to 86.96%.

Neutral/Negative Catalysts

Insider selling has increased by 575.77% over the last month.
Legal investigations and potential securities fraud allegations have created negative sentiment.
Analysts have significantly lowered price targets due to revenue guidance cuts and delayed revenue recognition.
The stock dropped 17.8% recently, reflecting investor concerns.

Financial Performance

In Q1 FY2026, Nutanix reported strong financial growth: Revenue increased to $670.58M (up 13.47% YoY), Net Income rose to $62.10M (up 107.50% YoY), and EPS improved to $0.21 (up 110.00% YoY). Gross margin also increased slightly to 86.96%. Despite these improvements, reduced revenue guidance and delayed revenue recognition have overshadowed the positive financial results.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts maintain mixed but generally cautious views. Most firms have lowered their price targets significantly, citing issues such as delayed revenue recognition and reduced FY26 guidance. However, many analysts retain Buy or Overweight ratings, indicating long-term potential. Price targets now range from $53 to $82, with a median target around $65.

14 Analyst Rating

Wall Street analysts forecast NTNX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NTNX is 70.42 USD with a low forecast of 53 USD and a high forecast of 90 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

12 Buy

2 Hold

0 Sell

Strong Buy

Current: 41.780

Low

Averages

70.42

High

Current: 41.780

Low

Averages

70.42

High

RBC Capital

Outperform

NULL

downgrade

$74 -> $65

AI Analysis

2026-01-05

Reason

RBC Capital

Price Target

$74 -> $65

AI Analysis

2026-01-05

downgrade

Outperform

NULL

Reason

RBC Capital lowered the firm's price target on Nutanix to $65 from $74 and keeps an Outperform rating on the shares. 2026 is likely to be a year when AI tailwinds become more evident for companies well positioned for enterprise AI adoption, while less prepared peers may remain pressured by the "AI is the death of software" narrative, the analyst tells investors in a research note. Enterprise spending appears to be stabilizing and improving in select areas, with GenAI driving innovation even as management teams remain conservative in early 2026 guidance, the firm says.

Goldman Sachs

Buy

downgrade

$95 -> $75

2025-11-28

Reason

Goldman Sachs

Price Target

$95 -> $75

2025-11-28

downgrade

Buy

Reason

Goldman Sachs lowered the firm's price target on Nutanix to $75 from $95 and keeps a Buy rating on the shares. The firm says the company's "noisy" fiscal Q1 report is more about deal timing than underlying demand. While the stock will likely remain range-bound in the near-term, with expectations now reset, Nutanix presents an attractive risk/reward, the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for NTNX

Unlock Now

NTNX Should I Buy

NTNX Should I Buy

Should You Buy Nutanix Inc (NTNX) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch